{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:30:51Z","timestamp":1781116251854,"version":"3.54.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1097\/md.0000000000008905","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T19:13:26Z","timestamp":1511378006000},"page":"e8905","source":"Crossref","is-referenced-by-count":8,"title":["Fimasartan-induced liver injury in a patient with no adverse reactions on other types of angiotensin II receptor blockers"],"prefix":"10.1097","volume":"96","author":[{"given":"Dae Hwa","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gee Young","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuk Soo","family":"Eun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Seok","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Hyung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Seok","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eaum Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-115-20210309","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40256-013-0004-9","article-title":"Safety and efficacy of fimasartan in patients with arterial hypertension (Safe-KanArb study): an open-label observational study","volume":"13","author":"Park","year":"2013","journal-title":"Am J Cardiovasc Drugs"},{"key":"R2-115-20210309","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/08037059609062128","article-title":"Marked hepatotoxicity associated with losartan treatment","volume":"5","author":"Nygaard","year":"1996","journal-title":"Blood Press"},{"key":"R3-115-20210309","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00004836-200205000-00022","article-title":"Losartan-induced hepatic injury","volume":"34","author":"Tabak","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"R4-115-20210309","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4103\/2249-4863.141635","article-title":"Losartan-induced ischemic hepatocellular hepatotoxicity: a case report and literature review","volume":"3","author":"Moh\u2019d","year":"2014","journal-title":"J Family Med Primary Care"},{"key":"R5-115-20210309","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00042737-200208000-00014","article-title":"Cholestatic hepatitis related to use of irbesartan: a case report and a literature review of angiotensin II antagonist-associated hepatotoxicity","volume":"14","author":"Andrade","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R6-115-20210309","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/bmj.321.7260.547","article-title":"Prolonged cholestasis associated with irbesartan","volume":"321","author":"Hariraj","year":"2000","journal-title":"BMJ"},{"key":"R7-115-20210309","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00004836-200303000-00017","article-title":"Candesartan cilexetil-induced severe hepatotoxicity","volume":"36","author":"Basile","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"R8-115-20210309","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s002280000220","article-title":"Candesartan and acute liver injury","volume":"56","author":"Gonzalez-Jimenez","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"R9-115-20210309","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/11593840-000000000-00000","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects","volume":"11","author":"Chi","year":"2011","journal-title":"Am J Cardiovasc Drugs"},{"key":"R11-115-20210309","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/FJC.0b013e318237389e","article-title":"Assessment of the drug\u2013drug interactions between fimasartan and hydrochlorothiazide in healthy volunteers","volume":"59","author":"Jeon","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"key":"R12-115-20210309","first-page":"249","article-title":"Am J Cardiovasc D","volume":"11","year":"2011","journal-title":"rugs"},{"key":"R13-115-20210309","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-2002-30105","article-title":"Epidemiology and individual susceptibility to adverse drug reactions affecting the liver","volume":"22","author":"Larrey","year":"2002","journal-title":"Semin Liver Dis"},{"key":"R14-115-20210309","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMra021844","article-title":"Drug-induced hepatotoxicity","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"R15-115-20210309","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jceh.2012.05.002","article-title":"An update on drug-induced liver injury","volume":"2","author":"Devarbhavi","year":"2012","journal-title":"J Clin Exp Hepatol"},{"key":"R16-115-20210309","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini","year":"2005","journal-title":"CMAJ"},{"key":"R17-115-20210309","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1001\/jama.1997.03550190036037","article-title":"Losartan-induced hepatotoxicity","volume":"278","author":"Bosch","year":"1997","journal-title":"JAMA"},{"key":"R18-115-20210309","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1345\/aph.18087a","article-title":"Hepatic injury associated with losartan","volume":"32","author":"Andrade","year":"1998","journal-title":"Ann Pharmacother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:44:26Z","timestamp":1620960266000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201711270-00115"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":17,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008905","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}